Literature DB >> 11471080

Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection.

J Diamant1, R Benis, J Schachter, J Moncada, F Pang, H C Jha, R C Bhatta, T Porco, T Lietman.   

Abstract

With the Global Elimination of Trachoma by 2020 program underway, it has become increasingly important to identify the prevalence of ocular chlamydia infection in communities. DNA amplification tests are the gold standard, but are prohibitively expensive. In the present paper, we investigate whether pooling multiple specimens into a single test is feasible. The conjunctivae of 170 children in western Nepal were examined and swabbed. The prevalence of chlamydial infection was estimated in two ways using the ligase chain reaction: by testing all 170 specimens individually, and by testing 34 pools of 5 specimens each. We show that the confidence interval for 34 pooled specimens approaches that of doing all 170 specimens as the prevalence decreases. We also determine the optimal number of specimens to pool into a single test to minimize the confidence interval of the estimate. If the population prevalence is expected to be around 10%, then 14 specimens should be pooled per test. Even at 50% prevalence, costs can be reduced by pooling two samples per test.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471080     DOI: 10.1076/opep.8.2.109.4156

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  32 in total

1.  Utility of pooled urine specimens for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in men attending public sexually transmitted infection clinics in Mumbai, India, by PCR.

Authors:  Christina Lindan; Meenakshi Mathur; Sameer Kumta; Hermangi Jerajani; Alka Gogate; Julius Schachter; Jeanne Moncada
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.

Authors:  Meron Haile; Zerihun Tadesse; Sintayehu Gebreselassie; Berhan Ayele; Teshome Gebre; Sun N Yu; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Paul M Emerson; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

3.  Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

Authors:  Emma M Harding-Esch; Tansy Edwards; Ansumana Sillah; Isatou Sarr; Chrissy H Roberts; Paul Snell; Esther Aryee; Sandra Molina; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2009-12-22

4.  School-Based versus Community-Based Sampling for Trachoma Surveillance.

Authors:  Joseph P Sheehan; Sintayehu Gebresillasie; Ayalew Shiferaw; Solomon Aragie; Zerihun Tadesse; Demelash Tadesse; Thanapong Somkijrungroj; Nicole E Stoller; E Kelly Callahan; Paul M Emerson; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

5.  Association of community antibiotic consumption with clinically active trachoma in rural Ethiopia.

Authors:  Berhan Ayele; Tesfaye Belay; Teshome Gebre; Mulat Zerihun; Abayneh Amere; Yared Assefa; Dereje Habte; Allison R Loh; Nicole E Stoller; Jeremy D Keenan
Journal:  Int Health       Date:  2011-12       Impact factor: 2.473

Review 6.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.

Authors:  L Dize; S K West; H Mkocha; T C Quinn; C A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-27       Impact factor: 2.803

8.  Trachoma rapid assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan.

Authors:  Emily Robinson; Lucia W Kur; Aggrey Ndyaba; Mounir Lado; Juma Shafi; Emmanuel Kabare; R Scott McClelland; Jan H Kolaczinski
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

9.  Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.

Authors:  Takele Lakew; Wondu Alemayehu; Muluken Melese; Elizabeth Yi; Jenafir I House; Kevin C Hong; Zhaoxia Zhou; Kathryn J Ray; Travis C Porco; Bruce D Gaynor; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

10.  When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.

Authors:  Kathryn J Ray; Thomas M Lietman; Travis C Porco; Jeremy D Keenan; Robin L Bailey; Anthony W Solomon; Matthew J Burton; Emma Harding-Esch; Martin J Holland; David Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.